HitGen
China - Chengdu
BiotechnologyFocus: DNA encoded library for drug discovery
HitGen is a life sciences company focused on DNA encoded library for drug discovery.
OncologyUnknown
Funding Stage
PUBLIC
Open Jobs
1
Pipeline & Clinical Trials
HG146
Solid TumorClinical Trials (1)
NCT04977167Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma
Phase 1HG146
Multiple MyelomaClinical Trials (1)
NCT03710915A Study of HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple Myeloma
Phase 1HG381
Advanced Solid TumorClinical Trials (1)
NCT04998422A Study of HG381 Administered to Patients With Advanced Solid Tumors
Phase 1Phase 2
Clinical Trials (1)
NCT06781567Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma
Phase 2Open Jobs (1)
Interview Prep Quick Facts
Founded: 2021
Portfolio: 4 clinical trials
Top TAs: Oncology
Publications: 25 in PubMed
Open Roles: 1 active job